A case report-volatile metabolomic signature of malignant melanoma using matching skin as a control

Journal of Cancer Science and Therapy

Volumn 3, Issue 6, 2011, Pages 140-144

  Abaffy, Tatjana ^a   Möller, Mecker ^a   Riemer, Daniel D ^b   Milikowski, Clara ^a   Defazio, R Anthony ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Biomarkers; GC MS; Melanoma; Metabolites; Volatile compounds

Indexed keywords

1 EICOSANOL; 1 HEXADECENE; 1 IODONONANE; 1,2 BENZENEDICARBOXYLIC ACID DIISOOCTYL ESTER; 1,3 CYCLOPENTADIENE 5 (1 METHYLETHYLIDENE); 1,3,5 TRIMETHYLBENZENE; 2 BUTOXYETHANOL; 2 ETHOXYETHYL ACRYLATE; 2 ETHYLHEXYL 4 METHOXYCINNAMATE; 2 ISOPROPYLAMINO 4 METHYLBENZONITRILE; 2 METHYL DECANE; 2,3,4 TRIMETHYL PENTANE; 2,4 DIMETHYL HEPTANE; 4 METHYL DECANE; 5' AMINO 5' DEOXYADENOSINE; ANISALDEHYDE; BIS (2 ETHYLHEXYL)PHTHALATE; DECANAL; DECANE; DICHLORODIFLUOROMETHANE; DODECANE; ETHYLCYCLOHEXANE; ETHYLENE OXIDE; FORMAMIDE; HEXADECANOL; ISOBUTYL 4 OCTYL ESTER PHTHALIC ACID; PALMITIC ACID ISOPROPYL ESTER; SPIRO(BICYCLO[2.2.1]HEPT 5 ENE 2,1' CYCLOPROPANE); UNCLASSIFIED DRUG; UNDECANE; VOLATILE ORGANIC COMPOUND;

ADULT; ARTICLE; CASE REPORT; COMPARATIVE STUDY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MASS FRAGMENTOGRAPHY; MELANOMA; METABOLOMICS; SKIN; SKIN BIOPSY; VOLATILE METABOLOMIC SIGNATURE;

EID: 84857081838     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000076     Document Type: Article

References (40)

1. Corona R, Mele A, Amini M, De Rosa G, Coppola G, et al. (1996) Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 14: 1218-1223.
2. Fritz V, Fajas L (2010) Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene 29: 4369-4377.
3. Jezek P, Plecita-Hlavata L, Smolkova K, Rossignol R (2010) Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development. Int J Biochem Cell Biol 42: 604-622.
4. Spratlin JL, Serkova NJ, Eckhardt SG (2009) Clinical applications of metabolomics in oncology: a review. Clin Cancer Res15: 431-440.
5. Locasale JW, Cantley LC (2009) Vander Heiden MG: Cancer's insatiable appetite. Nat Biotechnol 27: 916-917.
6. Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, et al. (2009) SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325: 1139-1142.
7. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, et al. (2009) Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325: 1555-1559.
8. Fernie AR, Trethewey RN, Krotzky AJ, Willmitzer L (2004) Metabolite profiling: from diagnostics to systems biology. Nat Rev Mol Cell Biol 5: 763-769.
9. Abaffy T, Duncan R, Riemer DD, Tietje O, Elgart G, et al. (2010) Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process. PLoS One 5: e13813.
10. Ackermann BL, Hale JE, Duffin KL (2006) The role of mass spectrometry in biomarker discovery and measurement. Curr Drug Metab 7: 525-539.
11. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914.
12. Pawliszyn J (2000) Theory of solid-phase microextraction. J Chromatogr Sci 38: 270-278.
13. Bernier UR, Kline DL, Barnard DR, Schreck CE, Yost RA (2000) Analysis of human skin emanations by gas chromatography/mass spectrometry. 2. Identification of volatile compounds that are candidate attractants for the yellow fever mosquito (Aedes aegypti). Anal Chem 72: 747-756.
14. Michael-Jubeli R, Bleton J, Baillet-Guffroy A (2011) High-temperature gas chromatography-mass spectrometry for skin surface lipids profiling. J Lipid Res 52: 143-151.
15. Kuhajda FP (2006) Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 66: 5977-5980.
16. Innocenzi D, Alo PL, Balzani A, Sebastiani V, Silipo V, et al. (2003) Fatty acid synthase expression in melanoma. J Cutan Pathol 30: 23-28.
17. Kapur P, Rakheja D, Roy LC, Hoang MP (2005) Fatty acid synthase expression in cutaneous melanocytic neoplasms. Mod Pathol 18: 1107-1112.
18. Bauer DE, Hatzivassiliou G, Zhao F, Andreadis C, Thompson CB (2005) ATP citrate lyase is an important component of cell growth and transformation. Oncogene 24: 6314-6322.
19. Nose K, Nunome Y, Kondo T, Araki S, Tsuda T (2005) Identification of gas emanated from human skin: methane, ethylene, and ethane. Anal Sci 21: 625-628.
20. Poulos A, Sharp P, Singh H, Johnson DW, Carey WF, et al. (1993) Formic acid is a product of the alpha-oxidation of fatty acids by human skin fibroblasts: deficiency of formic acid production in peroxisome-deficient fibroblasts. Biochem J 292: 457-461.
21. Baron S (1996) Medical microbiology. University of Texas Medical Branch at Galveston.
22. Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, et al. (2008) The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci 871: 164-173.
23. Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ (1984) Use of highresolution proton nuclear magnetic resonance spectroscopy for rapid multicomponent analysis of urine. Clin Chem 30: 426-432.
24. Smallegange RC, Qiu YT, van Loon JJ, Takken W (2005) Synergism between ammonia, lactic acid and carboxylic acids as kairomones in the host-seeking behaviour of the malaria mosquito Anopheles gambiae sensu stricto (Diptera: Culicidae). Chem Senses 30: 145-152.
25. Feron O (2009) Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol 92: 329-333.
26. Levine AJ, Puzio-Kuter AM (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330: 1340-1344.
27. Eng CH, Yu K, Lucas J, White E, Abraham RT (2010) Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci Signal 3: ra31.
28. DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, et al. (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 104: 19345-19350.
29. Zacharias DP, Lima MM, Souza AL Jr., de Abranches Oliveira Santos ID, Enokiara M, et al. (2003) Human cutaneous melanoma expresses a significant phosphate-dependent glutaminase activity: a comparison with the surrounding skin of the same patient. Cell Biochem Funct 21: 81-84.
30. Koch KA, Capitani G, Gruetter MG, Kirsch JF (2001) The human cDNA for a homologue of the plant enzyme 1-aminocyclopropane-1-carboxylate synthase encodes a protein lacking that activity. Gene 272: 75-84.
31. Tornqvist M, Gustafsson B, Kautiainen A, Harms-Ringdahl M, Granath F, et al. (1989) Unsaturated lipids and intestinal bacteria as sources of endogenous production of ethene and ethylene oxide. Carcinogenesis10: 39-41.
32. Clemens MR, Remmer H (1982) Volatile alkanes produced by erythrocytes: an assay for in vitro studies on lipid peroxidation. Blut 45: 329-335.
33. Bolt HM (1996) Quantification of endogenous carcinogens. The ethylene oxide paradox. Biochem Pharmacol 52: 1-5.
34. Cartoni A, Menna P, Salvatorelli E, Braghiroli D, Giampietro R, et al. (2004) Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin. J Biol Chem 279: 5088-5099.
35. Buczynski MW, Dumlao DS, Dennis EA (2009) Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res 50: 1015-1038.
36. Cormier SA, Taranova AG, Bedient C, Nguyen T, Protheroe C, et al. (2006) Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol 79: 1131-1139.
37. Mattes J, Hulett M, Xie W, Hogan S, Rothenberg ME, et al. (2003) Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. J Exp Med 197: 387-393.
38. Schmid MC, Varner JA (2010) Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation. J Oncol 2010: 201026.
39. Ntayi C, Lorimier S, Berthier-Vergnes O, Hornebeck W, Bernard P (2001) Cumulative influence of matrix metalloproteinase-1 and-2 in the migration of melanoma cells within three-dimensional type I collagen lattices. Exp Cell Res 270: 110-118.
40. Hofmann UB, Westphal JR, Waas ET, Zendman AJ, Cornelissen IM, et al. (1999) Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer 81: 774-782.